🔗 Share this article

An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to message these profiles directly for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in users injecting products of unknown origin.

Several experts said the demand for retatrutide could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and customer regulations, risking fines, prosecution or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the service has removed violative content and banned related hashtags and search suggestions. The organization said it was committed to keeping the platform secure and investing in strengthening compliance measures.

Digital Marketplace Activities

Research also discovered groups with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of slimming results, positive reviews and detailed guides for mixing or administering at residence.

Within minutes of entering one group, a vendor shared WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience.

Item Information and Costs

Inside these groups, posts display dark colored packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram stated it regularly monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject users to potentially serious medical dangers”.